Thank you for requesting 2017 Dealmakers' Intentions Study.

To download a copy of this document, please provide the following basic information:

Leave this field empty
    It's OK to send me occasional emails with new
perspectives from inVentiv Health Consulting

Now in its ninth year, the inVentiv Health Consulting Dealmakers' Intentions Study is the only forward-looking measure of dealmaking activity in the pharmaceutical and biotech industries. While there are many quality sources of information that look historically at past deal trends, this survey offers a prospective view of the partnering and licensing landscape for the year ahead. With insights gathered from dealmakers on the buy and sell side across the US, Europe and Asia, Dealmakers' Intentions presents conclusions that are crucial for C-suite executives, as well as executives responsible for dealmaking strategy and the business development function.
inVentiv Health Consulting offers world class healthcare consulting services.